Business News

Biocon gains as Pertuzumab biosimilar gets positive EMA recommendation

FinSiddhi

Biocon rose 1.94% to Rs 392.45 after its wholly owned subsidiary, Biocon Biologics, received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

In 1985, Andy Warhol created digital art on an Amiga computer; nearly 30 years later, researchers recovered 28 never-before-seen images from his floppy disks

In 1985, Andy Warhol experimented with digital art on an Amiga computer for a Commodore International commission. Nearly 30 years later, researchers recovered 28 previously unseen images from ageing floppy disks at The Andy Warhol Museum. The files had been trapped in an obsolete format and included works featuring Campbell’s soup cans, Venus, Marilyn Monroe…

Michigan shooting: 5 killed, 1 critically injured, gunman found dead after manhunt

Five people died in a northern Michigan shooting on Friday. The suspected gunman was later found dead after a large search. One other person sustained critical injuries and was hospitalized. Investigators discovered a fourth victim at another residence during the extensive search. The circumstances surrounding the deaths and the motive remain under investigation.